Advances in treatment and care in metastatic breast cancer (MBC): are there MBC patients who are curable?
نویسندگان
چکیده
منابع مشابه
Management Of Metastatic Breast Cancer (MBC).
UNLABELLED Chemotherapy of metastatic breast carcinoma so far, is not curative using the currently available chemotherapeutic, hormonal or biologic agents. The treatment of metastatic breast cancer is aimed mainly at alleviation of symptoms rather than cure. The first choice of therapy is dependent on patient age, performance status, hormone receptor status, human epidermal growth factor recept...
متن کاملComparison of Epidemiology and Drug Treatment in HER2 Negative Metastatic Breast Cancer (MBC) in EU5.
Poster Presented at the ISPOR 17the Annual European Congress │ 8-12 November 2014 │ Amsterdam, The Netherlands ©Copyright 2014 Kantar Health, 1 Independence Way Suite 220, Princeton, NJ 08540 USA, 609-720-5480 www.kantarhealth.com Prevalence of breast cancer (BC) ranged between 41-73 per 100K population across EU5. Among BC patients, prevalence of mBC was similar: 8% (UK, Italy) to 10% (G...
متن کاملThe Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC)
BACKGROUND Metastatic breast cancer (MBC) remains a devastating and incurable disease. Over the past decade, the implementation of clinical trials both with and without molecular targeted therapeutics has impacted the daily clinical treatment of patients with MBC. In this study, we determine whether including MBC patients in clinical trials affects clinical outcomes. METHODS We retrospectivel...
متن کاملAdvancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
Successful management of breast cancer in the metastatic setting is often confounded by resistance to chemotherapeutics, in particular anthracyclines and taxanes. The limited number of effective treatment options for patients with more aggressive biological subtypes, such as triple-negative metastatic breast cancer, is especially concerning. As such, a therapy clinically proven to be effective ...
متن کاملProlonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC).
BACKGROUND The aim of this retrospective analysis was to evaluate the impact of trastuzumab-based regimens on the survival of patients with HER2-overexpressing metastatic breast cancer (MBC). The study specifically focussed on the influence of the continuation of trastuzumab-based treatment despite tumor progression on survival. PATIENTS AND METHODS Patients with HER2 overexpressing MBC were ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chinese Clinical Oncology
سال: 2018
ISSN: 2304-3865,2304-3873
DOI: 10.21037/cco.2018.05.01